You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

53 Results
Guidelines and Advice
Status: Current
ID: GL 6-A-2023-1
Version: 2
Updated
Jan 2026
Guidelines and Advice
Status: Archived
ID: HPVTest
Apr 2006
Guidelines and Advice
Status: Archived
ID: 13-8
Oct 2006
Guidelines and Advice
Status: Current
ID: MCC
Jun 2006
Guidelines and Advice
Status: Education and Information
ID: 1-24 Version 2
Version: 2
May 2006
Guidelines and Advice
Status: Archived
ID: CED 3
Jan 2006
Guidelines and Advice
Status: Archived
ID: CED 2
Version: 2
Jan 2006
Guidelines and Advice
Status: Current
ID: GL 8-12
Updated
Jan 2026
Guidelines and Advice
Status: Archived
ID: 20-1
Aug 2006
Guidelines and Advice
Status: Current
ID: GL-C50-03
Apr 2006
Guidelines and Advice
Status: Current
ID: PET 2024-2
Updated
Jan 2026
Regimen
Cancer Type:
Head and Neck, 
Squamous Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant, Curative
Funding:
New Drug Funding Program
    Pembrolizumab - (Neo)adjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Updated
Feb 2026

Pages